NLRP3-IN-70
NLRP3-IN-70 (Compound 5m) is an NLRP3 inflammasome inhibitor with low oral bioavailability. NLRP3-IN-70 can directly bind to the NACHT domain of the NLRP3 protein and block the interaction of NLRP3 and ASC, thus inhibiting ASC oligomerization and NLRP3 inflammasome assembly. NLRP3-IN-70 can be used in the research of sepsis and nonalcoholic steatohepatitis[1].
Product Specifications
CAS Number
1997362-01-2
UNSPSC
12352005
Target
NOD-like Receptor (NLR)
Related Pathways
Immunology/Inflammation
Field of Research
Inflammation/Immunology
Smiles
O=C(C1=C(C2=C3C4=C(C(C)(CCC4)C)C=C2)OC=C1C(N5CCOCC5)=O)C3=O
Molecular Formula
C23H23NO5
Molecular Weight
393.43
References & Citations
[1]Zhu K, et al. Peripheral Evolution of Tanshinone IIA and Cryptotanshinone for Discovery of a Potent and Specific NLRP3 Inflammasome Inhibitor. J Med Chem. 2025 Feb 13;68 (3) :3460-3479.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
NLRP3
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880266-500 1x 500 µL
Human IgG Immunoglobulin (IG266), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400304-500 1x 500 µL
CD106 / VCAM1 (B-K9), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741118-500 1x 500 µL
Beta-2-Microglobulin (B2M) (B2M/1118), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471573-100 1x 100 µL
N-Cadherin / Cadherin-2 / CD325 (NCAD) (CDH2/1573), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042123-100 1x 100 µL
Mammaglobin (SCGB2A2) (Breast Cancer Marker) (MGB1/2123R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details